IBDEI0YG ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17121,0)
 ;;=285.29^^111^1075^6
 ;;^UTILITY(U,$J,358.3,17121,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17121,1,1,0)
 ;;=1^285.29
 ;;^UTILITY(U,$J,358.3,17121,1,8,0)
 ;;=8^Anemia Oth Chronic Illness
 ;;^UTILITY(U,$J,358.3,17121,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,17122,0)
 ;;=285.1^^111^1075^1
 ;;^UTILITY(U,$J,358.3,17122,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17122,1,1,0)
 ;;=1^285.1
 ;;^UTILITY(U,$J,358.3,17122,1,8,0)
 ;;=8^Ac Posthemorrhag Anemia
 ;;^UTILITY(U,$J,358.3,17122,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,17123,0)
 ;;=284.2^^111^1075^30
 ;;^UTILITY(U,$J,358.3,17123,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17123,1,1,0)
 ;;=1^284.2
 ;;^UTILITY(U,$J,358.3,17123,1,8,0)
 ;;=8^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,17123,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,17124,0)
 ;;=281.9^^111^1075^14
 ;;^UTILITY(U,$J,358.3,17124,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17124,1,1,0)
 ;;=1^281.9
 ;;^UTILITY(U,$J,358.3,17124,1,8,0)
 ;;=8^Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,17124,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,17125,0)
 ;;=282.41^^111^1075^46
 ;;^UTILITY(U,$J,358.3,17125,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17125,1,1,0)
 ;;=1^282.41
 ;;^UTILITY(U,$J,358.3,17125,1,8,0)
 ;;=8^Sickle Cell Thalassemia w/o crisis
 ;;^UTILITY(U,$J,358.3,17125,2)
 ;;=^329908
 ;;^UTILITY(U,$J,358.3,17126,0)
 ;;=284.11^^111^1075^10
 ;;^UTILITY(U,$J,358.3,17126,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17126,1,1,0)
 ;;=1^284.11
 ;;^UTILITY(U,$J,358.3,17126,1,8,0)
 ;;=8^Antineoplastic Chemo Indcd Panycyt
 ;;^UTILITY(U,$J,358.3,17126,2)
 ;;=^340499
 ;;^UTILITY(U,$J,358.3,17127,0)
 ;;=284.12^^111^1075^33
 ;;^UTILITY(U,$J,358.3,17127,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17127,1,1,0)
 ;;=1^284.12
 ;;^UTILITY(U,$J,358.3,17127,1,8,0)
 ;;=8^Oth Drug Indcd Pancytopenia
 ;;^UTILITY(U,$J,358.3,17127,2)
 ;;=^340500
 ;;^UTILITY(U,$J,358.3,17128,0)
 ;;=284.19^^111^1075^36
 ;;^UTILITY(U,$J,358.3,17128,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17128,1,1,0)
 ;;=1^284.19
 ;;^UTILITY(U,$J,358.3,17128,1,8,0)
 ;;=8^Oth Pancytopenia
 ;;^UTILITY(U,$J,358.3,17128,2)
 ;;=^340501
 ;;^UTILITY(U,$J,358.3,17129,0)
 ;;=281.1^^111^1075^43
 ;;^UTILITY(U,$J,358.3,17129,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17129,1,1,0)
 ;;=1^281.1
 ;;^UTILITY(U,$J,358.3,17129,1,8,0)
 ;;=8^Oth Vit B12 Deficiency Anemia
 ;;^UTILITY(U,$J,358.3,17129,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,17130,0)
 ;;=281.2^^111^1075^16
 ;;^UTILITY(U,$J,358.3,17130,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17130,1,1,0)
 ;;=1^281.2
 ;;^UTILITY(U,$J,358.3,17130,1,8,0)
 ;;=8^Folate-deficiency Anemia
 ;;^UTILITY(U,$J,358.3,17130,2)
 ;;=^259686
 ;;^UTILITY(U,$J,358.3,17131,0)
 ;;=281.3^^111^1075^41
 ;;^UTILITY(U,$J,358.3,17131,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17131,1,1,0)
 ;;=1^281.3
 ;;^UTILITY(U,$J,358.3,17131,1,8,0)
 ;;=8^Oth Spec Megaloblastic Anemia NEC
 ;;^UTILITY(U,$J,358.3,17131,2)
 ;;=^88100
 ;;^UTILITY(U,$J,358.3,17132,0)
 ;;=281.4^^111^1075^45
 ;;^UTILITY(U,$J,358.3,17132,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17132,1,1,0)
 ;;=1^281.4
 ;;^UTILITY(U,$J,358.3,17132,1,8,0)
 ;;=8^Protein-deficiency Anemia
 ;;^UTILITY(U,$J,358.3,17132,2)
 ;;=^267975
 ;;^UTILITY(U,$J,358.3,17133,0)
 ;;=282.0^^111^1075^25
 ;;^UTILITY(U,$J,358.3,17133,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17133,1,1,0)
 ;;=1^282.0
 ;;^UTILITY(U,$J,358.3,17133,1,8,0)
 ;;=8^Hereditary Spherocytosis
 ;;^UTILITY(U,$J,358.3,17133,2)
 ;;=^113079
 ;;^UTILITY(U,$J,358.3,17134,0)
 ;;=282.1^^111^1075^23
 ;;^UTILITY(U,$J,358.3,17134,1,0)
 ;;=^358.31IA^8^2
